Psychedelics Archives

Green Market Report

Home
News Briefs
Spotlight
Videos
Events
- Crain’s Cleveland Business Cannabis Summit
- Upcoming Events
Awards
- 2023 Notable Leaders in Cannabis

Debra BorchardtDecember 14, 2023

A Seattle doctor is not giving up when it comes to the rescheduling of psilocybin. While the focus on rescheduling cannabis is talked about constantly, psilocybin also faces the same dilemma of being a schedule one drug. Law360 reported that Seattle physician Dr. Sunil Aggarwal filed a petition on Dec. 11, nearly two months after […]

John SchroyerDecember 12, 2023

The FDA has 60 days to decide if the application will be accepted for review.

Debra BorchardtDecember 11, 2023

The author suggests synthetic psychedelics may have a better chance for federal legalization.

Debra BorchardtDecember 11, 2023

The company is targeting a listing on the Australian Securities Exchange.

John SchroyerDecember 6, 2023

The firm secured a 10% interest rate on the new financing.

John SchroyerDecember 6, 2023

The push toward mainstream legitimacy is largely what's fueled the rise in dealmaking.

Debra BorchardtDecember 5, 2023

The company expects to launch a Phase 2 study in the first quarter of 2024.

John SchroyerDecember 5, 2023

Executives said the merger will give Serenus a better shot at global expansion.

Debra BorchardtNovember 30, 2023

The company is reviewing strategic alternatives including selling the company.

Adam JacksonNovember 30, 2023

The firm linked tighter margins to aggressive investment in full-time practitioners.

Newer Posts

Older Posts

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis

Recent Tweets

Company

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

In other news

The Daily Hit: January 4, 2024

Connecticut Attorney General Tells Unlicensed Cannabis Events Company to Stop

Testing Concerns Lead to Quarantine for 70% of Mississippi MMJ Goods

Category: Psychedelics

Push For Psilocybin Rescheduling Amps Up

MAPS Submits New Drug Application to FDA for MDMA Treatment

Psychedelics on Collision Course with FDA, Says New JAMA Article

Exopharm to Buy Tryp Therapeutics in All-Stock Deal

Filament Health Finds New Financing in Quest for Nasdaq Uplisting

Psychedelic Deals, Partnerships Skyrocket 500% Since 2019

Gilgamesh Pharmaceuticals Gets Positive Results on Fast-Acting Psychedelic

3Win Corp. to Acquire Serenus Global

Braxia Scientific Low on Cash and Looking for a Deal

Numinus Posts Revenue Surge for Fiscal 2023

The Daily Hit - TEST TEST TEST

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

Get the latest cannabis news delivered right to your inbox